Thorax

Papers
(The H4-Index of Thorax is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19563
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort391
Respiratory follow-up of patients with COVID-19 pneumonia245
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study219
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms217
Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study201
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis198
COVID-19: in the footsteps of Ernest Shackleton140
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease132
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length131
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial130
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations129
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey125
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort117
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection109
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people90
BTS Clinical Statement on pulmonary sarcoidosis87
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-1985
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p84
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-1982
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era81
Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS79
Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review75
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait71
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide68
Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales68
Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data65
Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study63
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection63
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study63
Severe organising pneumonia following COVID-1960
Awake prone positioning in COVID-1958
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)57
Neutrophils in asthma: the good, the bad and the bacteria57
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score56
Night shift work is associated with an increased risk of asthma56
Bacterial biofilms predominate in both acute and chronic human lung infections54
COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations50
Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases50
Variation in oral microbiome is associated with future risk of lung cancer among never-smokers49
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-1949
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life47
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis47
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study47
Applications of artificial intelligence and machine learning in respiratory medicine46
Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis45
0.05632495880127